BNP Paribas Financial Markets’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$238K Buy
2,096
+680
+48% +$77.3K ﹤0.01% 2915
2025
Q1
$149K Sell
1,416
-1,012
-42% -$106K ﹤0.01% 3048
2024
Q4
$260K Sell
2,428
-1,728
-42% -$185K ﹤0.01% 2892
2024
Q3
$416K Sell
4,156
-1,586
-28% -$159K ﹤0.01% 2231
2024
Q2
$484K Sell
5,742
-3,554
-38% -$299K ﹤0.01% 2040
2024
Q1
$680K Sell
9,296
-9,186
-50% -$671K ﹤0.01% 2063
2023
Q4
$1.32M Sell
18,482
-2,299
-11% -$164K ﹤0.01% 1618
2023
Q3
$1.25M Buy
20,781
+15,069
+264% +$903K ﹤0.01% 1615
2023
Q2
$412K Sell
5,712
-5,123
-47% -$369K ﹤0.01% 2092
2023
Q1
$797K Buy
10,835
+7,023
+184% +$517K ﹤0.01% 1891
2022
Q4
$255K Sell
3,812
-23,237
-86% -$1.55M ﹤0.01% 2269
2022
Q3
$1.45M Buy
27,049
+20,187
+294% +$1.08M ﹤0.01% 1632
2022
Q2
$382K Sell
6,862
-1,222
-15% -$68K ﹤0.01% 2186
2022
Q1
$567K Sell
8,084
-8,278
-51% -$581K ﹤0.01% 2142
2021
Q4
$1.58M Sell
16,362
-11,444
-41% -$1.1M ﹤0.01% 1717
2021
Q3
$2.42M Buy
27,806
+22,686
+443% +$1.97M ﹤0.01% 1297
2021
Q2
$419K Sell
5,120
-870
-15% -$71.2K ﹤0.01% 2045
2021
Q1
$570K Buy
5,990
+2,511
+72% +$239K ﹤0.01% 1986
2020
Q4
$216K Buy
3,479
+23
+0.7% +$1.43K ﹤0.01% 2218
2020
Q3
$206K Sell
3,456
-1,210
-26% -$72K ﹤0.01% 2152
2020
Q2
$326K Sell
4,666
-19,103
-80% -$1.33M ﹤0.01% 1691
2020
Q1
$1.08M Buy
23,769
+18,450
+347% +$837K ﹤0.01% 1384
2019
Q4
$346K Sell
5,319
-360
-6% -$23.4K ﹤0.01% 2061
2019
Q3
$353K Buy
5,679
+2,151
+61% +$134K ﹤0.01% 1803
2019
Q2
$251K Sell
3,528
-3,524
-50% -$251K ﹤0.01% 1874
2019
Q1
$553K Buy
7,052
+4,994
+243% +$392K ﹤0.01% 1513
2018
Q4
$174K Sell
2,058
-3,795
-65% -$321K ﹤0.01% 1495
2018
Q3
$1M Buy
5,853
+2,214
+61% +$379K ﹤0.01% 1225
2018
Q2
$470K Sell
3,639
-7,135
-66% -$922K ﹤0.01% 1469
2018
Q1
$1.11M Sell
10,774
-3,047
-22% -$314K ﹤0.01% 1195
2017
Q4
$1.18M Sell
13,821
-3,562
-20% -$304K ﹤0.01% 1307
2017
Q3
$1.48M Buy
17,383
+7,504
+76% +$637K ﹤0.01% 1178
2017
Q2
$748K Sell
9,879
-834
-8% -$63.2K ﹤0.01% 1484
2017
Q1
$707K Buy
10,713
+1,342
+14% +$88.6K ﹤0.01% 1328
2016
Q4
$594K Buy
9,371
+4,533
+94% +$287K ﹤0.01% 1359
2016
Q3
$308K Sell
4,838
-4,652
-49% -$296K ﹤0.01% 1497
2016
Q2
$706K Buy
9,490
+5,450
+135% +$405K ﹤0.01% 1333
2016
Q1
$270K Sell
4,040
-3,658
-48% -$244K ﹤0.01% 1419
2015
Q4
$521K Buy
7,698
+2,011
+35% +$136K ﹤0.01% 1348
2015
Q3
$304K Buy
5,687
+3,347
+143% +$179K ﹤0.01% 1679
2015
Q2
$147K Buy
2,340
+1,593
+213% +$100K ﹤0.01% 1882
2015
Q1
$35.9K Buy
+747
New +$35.9K ﹤0.01% 2086
2014
Q4
Sell
-8,877
Closed -$260K 2407
2014
Q3
$260K Buy
8,877
+8,839
+23,261% +$259K ﹤0.01% 1495
2014
Q2
$1.5K Buy
+38
New +$1.5K ﹤0.01% 2779
2014
Q1
Sell
-369
Closed -$12.1K 3092
2013
Q4
$12.1K Sell
369
-7,305
-95% -$240K ﹤0.01% 2076
2013
Q3
$207K Sell
7,674
-2,225
-22% -$60.1K ﹤0.01% 1902
2013
Q2
$231K Buy
+9,899
New +$231K ﹤0.01% 1900